US Spinal Cord Stimulator Market

ID: MRFR/HC/13096-HCR
100 Pages
Vikita Thakur
Last Updated: May 13, 2026
US Spinal Cord Stimulator Market Research Report: By Product Type (Traditional Spinal Cord Stimulators, Rechargeable Spinal Cord Stimulators, Non-Rechargeable Spinal Cord Stimulators), By Application (Chronic Pain Management, Neuropathic Pain Management, Failed Back Surgery Syndrome), By End User (Hospitals, Ambulatory Surgical Centers, Pain Clinics) and By Technology (Closed Loop Systems, Open Loop Systems, Wireless Systems) - Growth & Industry Forecast 2025 To 2035
US Spinal Cord Stimulator Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.71%
2024 Market Size$ 977.55 Million
2025 Market Size$ 1,033.37 Million
2035 Market Size$ 1,800 Million
Key Players
Medtronic
Boston Scientific
Abbott
Nevro
Stimwave
Stryker
Trends
  • Technological Advancements
  • Regulatory Changes
  • Aging Population
Opportunities
  • Rising Prevalence of Chronic Pain
  • Expansion of Reimbursement Policies
  • Increased Investment in Healthcare Technology
Summary Table of Contents Segmentation Download PDF
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Life Sciences, BY Type (USD Million) | |
      1. 4.1.1 Non-Implantable | |
      2. 4.1.2 Implantable | |
      3. 4.1.3 Rechargeable | |
      4. 4.1.4 Non-Rechargeable |
    2. 4.2 Life Sciences, BY Application (USD Million) | |
      1. 4.2.1 Chronic Pain Management | |
      2. 4.2.2 Neuropathic Pain | |
      3. 4.2.3 Decompression Syndrome | |
      4. 4.2.4 Failed Back Surgery Syndrome |
    3. 4.3 Life Sciences, BY End User (USD Million) | |
      1. 4.3.1 Hospitals | |
      2. 4.3.2 Ambulatory Surgical Centers | |
      3. 4.3.3 Pain Management Clinics | |
      4. 4.3.4 Home Care Settings |
    4. 4.4 Life Sciences, BY Technology (USD Million) | |
      1. 4.4.1 Conventional Spinal Cord Stimulators | |
      2. 4.4.2 Burst Spinal Cord Stimulators | |
      3. 4.4.3 High-Frequency Spinal Cord Stimulators 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Life Sciences | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Medtronic (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Boston Scientific (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Abbott (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Nevro (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Stimwave (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Stryker (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Nuvectra (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Horizon Therapeutics (IE) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 US MARKET ANALYSIS BY TYPE |
    6. 6.3 US MARKET ANALYSIS BY APPLICATION |
    7. 6.4 US MARKET ANALYSIS BY END USER |
    8. 6.5 US MARKET ANALYSIS BY TECHNOLOGY |
    9. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES |
    10. 6.7 RESEARCH PROCESS OF MRFR |
    11. 6.8 DRO ANALYSIS OF LIFE SCIENCES |
    12. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES |
    13. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES |
    14. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES |
    15. 6.12 LIFE SCIENCES, BY TYPE, 2024 (% SHARE) |
    16. 6.13 LIFE SCIENCES, BY TYPE, 2024 TO 2035 (USD Million) |
    17. 6.14 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE) |
    18. 6.15 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million) |
    19. 6.16 LIFE SCIENCES, BY END USER, 2024 (% SHARE) |
    20. 6.17 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million) |
    21. 6.18 LIFE SCIENCES, BY TECHNOLOGY, 2024 (% SHARE) |
    22. 6.19 LIFE SCIENCES, BY TECHNOLOGY, 2024 TO 2035 (USD Million) |
    23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    24. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    25. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million) | |
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.2.3 BY END USER, 2025-2035 (USD Million) | |
      4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million) |
    26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    27. 7.4 ACQUISITION/PARTNERSHIP | |

US Spinal Cord Stimulator Market Segmentation

US Spinal Cord Stimulator Market By Type (USD Million, 2025-2035)

  • Non-Implantable
  • Implantable
  • Rechargeable
  • Non-Rechargeable

US Spinal Cord Stimulator Market By Application (USD Million, 2025-2035)

  • Chronic Pain Management
  • Neuropathic Pain
  • Decompression Syndrome
  • Failed Back Surgery Syndrome

US Spinal Cord Stimulator Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Pain Management Clinics
  • Home Care Settings

US Spinal Cord Stimulator Market By Technology (USD Million, 2025-2035)

  • Conventional Spinal Cord Stimulators
  • Burst Spinal Cord Stimulators
  • High-Frequency Spinal Cord Stimulators

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.